comprehensive
Previous article:
Supreme Court strikes down use of affirmative action
Next article: Patient advocates debate FDA's accelerated approval process
Next article: Patient advocates debate FDA's accelerated approval process
leisure time
leisure time
-
STAT's guide to the next generation of CAR
2025-10-01 17:12 -
Merck drug for rare lung condition set for approval in U.S.
2025-10-01 16:37 -
Why are elite athletes different? Take a look at their microbes
2025-10-01 15:40 -
Why are elite athletes different? Take a look at their microbes
2025-10-01 15:18 -
With FDA staff opposed to Sarepta therapy, top official intervened
2025-10-01 15:14 -
FDA's naming rule on biosimilars has undermined competition
2025-10-01 14:44